BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 32647118)

  • 1. Aberrantly expressed HORMAD1 disrupts nuclear localization of MCM8-MCM9 complex and compromises DNA mismatch repair in cancer cells.
    Liu K; Wang Y; Zhu Q; Li P; Chen J; Tang Z; Shen Y; Cheng X; Lu LY; Liu Y
    Cell Death Dis; 2020 Jul; 11(7):519. PubMed ID: 32647118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meiotic cohesins mediate initial loading of HORMAD1 to the chromosomes and coordinate SC formation during meiotic prophase.
    Fujiwara Y; Horisawa-Takada Y; Inoue E; Tani N; Shibuya H; Fujimura S; Kariyazono R; Sakata T; Ohta K; Araki K; Okada Y; Ishiguro KI
    PLoS Genet; 2020 Sep; 16(9):e1009048. PubMed ID: 32931493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MCM9 Is Required for Mammalian DNA Mismatch Repair.
    Traver S; Coulombe P; Peiffer I; Hutchins JR; Kitzmann M; Latreille D; Méchali M
    Mol Cell; 2015 Sep; 59(5):831-9. PubMed ID: 26300262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ectopically Expressed Meiosis-Specific Cancer Testis Antigen HORMAD1 Promotes Genomic Instability in Squamous Cell Carcinomas.
    Gantchev J; Messina-Pacheco J; Martínez Villarreal A; Ramchatesingh B; Lefrançois P; Xie P; Amar L; Xu HH; Raveendra K; Sikorski D; Guerra Ordaz DJ; Gill RPK; Lambert M; Litvinov IV
    Cells; 2023 Jun; 12(12):. PubMed ID: 37371097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The MCM8-MCM9 complex promotes RAD51 recruitment at DNA damage sites to facilitate homologous recombination.
    Park J; Long DT; Lee KY; Abbas T; Shibata E; Negishi M; Luo Y; Schimenti JC; Gambus A; Walter JC; Dutta A
    Mol Cell Biol; 2013 Apr; 33(8):1632-44. PubMed ID: 23401855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Cancer/Testes (CT) Antigen HORMAD1 promotes Homologous Recombinational DNA Repair and Radioresistance in Lung adenocarcinoma cells.
    Gao Y; Kardos J; Yang Y; Tamir TY; Mutter-Rottmayer E; Weissman B; Major MB; Kim WY; Vaziri C
    Sci Rep; 2018 Oct; 8(1):15304. PubMed ID: 30333500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repair of exogenous DNA double-strand breaks promotes chromosome synapsis in SPO11-mutant mouse meiocytes, and is altered in the absence of HORMAD1.
    Carofiglio F; Sleddens-Linkels E; Wassenaar E; Inagaki A; van Cappellen WA; Grootegoed JA; Toth A; Baarends WM
    DNA Repair (Amst); 2018 Mar; 63():25-38. PubMed ID: 29414051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MCM8- and MCM9-deficient mice reveal gametogenesis defects and genome instability due to impaired homologous recombination.
    Lutzmann M; Grey C; Traver S; Ganier O; Maya-Mendoza A; Ranisavljevic N; Bernex F; Nishiyama A; Montel N; Gavois E; Forichon L; de Massy B; Méchali M
    Mol Cell; 2012 Aug; 47(4):523-34. PubMed ID: 22771120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel mammalian HORMA domain-containing protein, HORMAD1, preferentially associates with unsynapsed meiotic chromosomes.
    Fukuda T; Daniel K; Wojtasz L; Toth A; Höög C
    Exp Cell Res; 2010 Jan; 316(2):158-71. PubMed ID: 19686734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural and biochemical insights into the interaction mechanism underlying HORMAD1 and its partner proteins.
    Wang H; Xie R; Niu F; Yang Q; An L; Wu C; Liu X; Yang X
    Structure; 2023 Dec; 31(12):1578-1588.e3. PubMed ID: 37794593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cancer testes antigen, HORMAD1, limits genomic instability in cancer cells by protecting stalled replication forks.
    Herrera LR; Johnson RA; McGlynn K; Gibbs ZA; Davis AJ; Whitehurst AW
    J Biol Chem; 2023 Nov; 299(11):105348. PubMed ID: 37838177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MCM8-9 complex promotes resection of double-strand break ends by MRE11-RAD50-NBS1 complex.
    Lee KY; Im JS; Shibata E; Park J; Handa N; Kowalczykowski SC; Dutta A
    Nat Commun; 2015 Jul; 6():7744. PubMed ID: 26215093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HORMAD1-dependent checkpoint/surveillance mechanism eliminates asynaptic oocytes.
    Kogo H; Tsutsumi M; Ohye T; Inagaki H; Abe T; Kurahashi H
    Genes Cells; 2012 Jun; 17(6):439-54. PubMed ID: 22530760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meiotic homologue alignment and its quality surveillance are controlled by mouse HORMAD1.
    Daniel K; Lange J; Hached K; Fu J; Anastassiadis K; Roig I; Cooke HJ; Stewart AF; Wassmann K; Jasin M; Keeney S; Tóth A
    Nat Cell Biol; 2011 May; 13(5):599-610. PubMed ID: 21478856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular functions of MCM8 and MCM9 and their associated pathologies.
    Helderman NC; Terlouw D; Bonjoch L; Golubicki M; Antelo M; Morreau H; van Wezel T; Castellví-Bel S; Goldberg Y; Nielsen M
    iScience; 2023 Jun; 26(6):106737. PubMed ID: 37378315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibiting the MCM8-9 complex selectively sensitizes cancer cells to cisplatin and olaparib.
    Morii I; Iwabuchi Y; Mori S; Suekuni M; Natsume T; Yoshida K; Sugimoto N; Kanemaki MT; Fujita M
    Cancer Sci; 2019 Mar; 110(3):1044-1053. PubMed ID: 30648820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HORMAD1 Is a Negative Prognostic Indicator in Lung Adenocarcinoma and Specifies Resistance to Oxidative and Genotoxic Stress.
    Nichols BA; Oswald NW; McMillan EA; McGlynn K; Yan J; Kim MS; Saha J; Mallipeddi PL; LaDuke SA; Villalobos PA; Rodriguez-Canales J; Wistuba II; Posner BA; Davis AJ; Minna JD; MacMillan JB; Whitehurst AW
    Cancer Res; 2018 Nov; 78(21):6196-6208. PubMed ID: 30185546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MCM8 and MCM9 Nucleotide Variants in Women With Primary Ovarian Insufficiency.
    Desai S; Wood-Trageser M; Matic J; Chipkin J; Jiang H; Bachelot A; Dulon J; Sala C; Barbieri C; Cocca M; Toniolo D; Touraine P; Witchel S; Rajkovic A
    J Clin Endocrinol Metab; 2017 Feb; 102(2):576-582. PubMed ID: 27802094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MCM8- and MCM9 Deficiencies Cause Lifelong Increased Hematopoietic DNA Damage Driving p53-Dependent Myeloid Tumors.
    Lutzmann M; Bernex F; da Costa de Jesus C; Hodroj D; Marty C; Plo I; Vainchenker W; Tosolini M; Forichon L; Bret C; Queille S; Marchive C; Hoffmann JS; Méchali M
    Cell Rep; 2019 Sep; 28(11):2851-2865.e4. PubMed ID: 31509747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Control of homologous recombination by the HROB-MCM8-MCM9 pathway.
    Hustedt N; Saito Y; Zimmermann M; Álvarez-Quilón A; Setiaputra D; Adam S; McEwan A; Yuan JY; Olivieri M; Zhao Y; Kanemaki MT; Jurisicova A; Durocher D
    Genes Dev; 2019 Oct; 33(19-20):1397-1415. PubMed ID: 31467087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.